Saturday, July 19, 2008

Teva still better than Sandoz?

Back on June 5th, I posted about Daniel Vasella, CEO of Novartis, being quoted as saying,

“Teva is better than we are, and that’s hard to take."

I would love to hear his take on the recent announcement of Teva's acquisition of Barr.
What is he saying now?

No comments: